{"url_path":"/sec/limnw/8-k/2026-06-03/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-26-070173-index.html","accession_number":"0001104659-26-070173","cik":"0001971387","ticker":"LIMN","issuer_name":"Liminatus Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-26-070173-index.html","primary_entity_key":"0001971387","primary_entity_name":"Liminatus Pharma, Inc."},"word_count":96,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n \n\n(d) Exhibits.\n\n \n\nExhibit\nNo. \nDescription\n\n[4.1](tm2616851d1_ex4-1.htm) \n[Form of New Black-Scholes Warrant](tm2616851d1_ex4-1.htm)\n\n[4.2](tm2616851d1_ex4-2.htm) \n[Form of New Change of Control Warrant](tm2616851d1_ex4-2.htm)\n\n[10.1](tm2616851d1_ex10-1.htm) \n[Form of Inducement Letter](tm2616851d1_ex10-1.htm)\n\n[99.1](tm2616851d1_ex99-1.htm) \n[Press Release](tm2616851d1_ex99-1.htm)\n\n104 \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n3 \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDated: June 3, 2026\n \n \n\n \n \n \n\n \nLIMINATUS PHARMA, INC.\n\n \n \n \n\n \nBy:\n/s/ Chris Kim \n\n \nName: \nChris Kim\n\n \nTitle:\nChief Executive Officer\n\n \n\n4"}